Trials / Conditions / Allergic Rhinitis Due to Grass Pollen

Allergic Rhinitis Due to Grass Pollen

11 registered clinical trials studyying Allergic Rhinitis Due to Grass Pollen — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With NCT06061848	Lars Olaf Cardell	Phase 2 / Phase 3
Completed	Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergi NCT06104293	Alyatec	N/A
Completed	Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract NCT05297760	University of Zurich	Phase 1 / Phase 2
Completed	Kinetics of Nasal Cytokine Responses to Mechanical Stimulation NCT04878237	Medical University of Vienna	N/A
Completed	The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells NCT04802616	Medical University of Lublin	Phase 3
Completed	ILIT: Follow-up of Rhinitis Quality of Life NCT05037955	University of Zurich	—
Unknown	Efficacy of Puressentiel Protective Nasal Spray in Allergic Rhinitis NCT04700852	Puressentiel	N/A
Completed	Documentation of Efficacy of Intralymphatic Allergen Immunotherapy NCT05191186	Aarhus University Hospital	Phase 3
Completed	Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects NCT03290248	AOBiome LLC	Phase 1 / Phase 2
Completed	Is Intralymphatic Allergen Immunotherapy Effective and Safe? NCT04210193	Lars Olaf Cardell	Phase 2 / Phase 3
Completed	Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhini NCT01953471	Hopital Foch	—